Skip to main content
logo
Eris Lifesciences Limited (BOM:540596)
India flag India · Delayed Price · Currency is INR
1,352.75
-22.85 (-1.66%)
At close: Jul 31, 2026

Eris Lifesciences Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
32,12431,14928,79319,91316,61813,262
Revenue Growth
9.44%8.18%44.59%19.83%25.31%11.20%
Gross Profit
23,62223,19321,46115,95013,00510,621
Operating Income
8,5868,4067,0274,9454,2174,245
Net Income
6,4396,1953,5183,9213,8224,061
Earnings Per Share
46.8545.2625.8128.7928.0729.88
EPS Growth
65.23%75.36%-10.35%2.56%-6.06%14.31%

Revenue by Geography
Chart
Fiscal YearFY 2025FY 2024FY 2023FY 2022
Period EndingMar '25 Mar '24 Mar '23 Mar '22
India
26,37519,44816,61813,262
outside India
2,418465.2--
Total
28,79319,91316,61813,262

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
6736732,05513,389860.292,123
Total Debt
23,58623,58624,77927,8138,918936.66
Net Cash (Debt)
-22,913-22,913-22,725-14,424-8,0581,187
Net Cash Growth
-----5.46%
Net Cash Per Share
-166.72-167.40-166.73-105.93-59.188.73

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-5,38010,6504,8602,9173,783
Capital Expenditures
--2,969-1,550-1,292-8,414-1,210
Free Cash Flow
-2,4119,1003,569-5,4972,572
Free Cash Flow Growth
--73.50%155.01%---26.42%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
73.53%74.46%74.53%80.10%78.26%80.09%
Operating Margin
26.73%26.99%24.40%24.83%25.37%32.01%
Pretax Margin
20.45%20.50%16.98%21.66%24.35%33.34%
Profit Margin
20.04%19.89%12.22%19.69%23.00%30.62%
FCF Margin
-7.74%31.61%17.92%-33.08%19.40%

Dividends
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
7.2107.2107.350-7.3506.010
Dividend Per Share Growth
0%-1.91%--22.30%9.27%
Dividend Yield
0.53%0.56%0.52%-1.30%0.89%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
29.1529.0154.8529.2620.3623.05
P/FCF Ratio
77.8574.5321.2132.15-36.39
PS Ratio
5.845.776.705.764.687.06